# Sanofi selects Recursion drug candidate, triggering $10 million payment

_Published Thursday, October 15, 2026 at 12:19 PM EDT · AI · Latest · Tier 2 — Notable_

![Sanofi selects Recursion drug candidate, triggering $10 million payment — Primary](https://cdn.rttnews.com/images/v4/RTTNews-logo-512x512.png)

Recursion said Sanofi selected the first development candidate from their AI-driven drug discovery collaboration, triggering a $10 million milestone payment. The potential oral treatment targets two proteins implicated in inflammatory diseases.

Sanofi will fund and lead further development and commercialization, with Phase 1 trials planned for 2027. Recursion said the selection ends its operational obligations for this candidate. The milestone brings total upfront and milestone payments under the collaboration to $144 million; additional milestones and sales royalties depend on further progress.

## Sources

- [RTTNews](https://www.rttnews.com/3699473/recursion-to-receive-10-mln-milestone-payment-as-sanofi-selects-immunology-drug-candidate.aspx)

---
Canonical: https://techandbusiness.org/newswire/zXSclgtEMTxLGK0WtIMnF7
Published: 2026-10-15T16:19:29.857Z
Story chronology: 2026-10-15T14:55:07.000Z
Retrieved: 2026-10-15T19:00:46.706Z
Publisher: Tech & Business (techandbusiness.org)